No information was found regarding discounts for the Aristada Initio kit.
What is Aristada Initio?
Aristada Initio is a combination therapy that includes a starter dosage of Aristada (aripiprazole lauroxil) along with a single dose of the Aristada maintenance injection [1]. It is used to initiate treatment with Aristada, an antipsychotic medication used to treat schizophrenia in adults [1].
How does Aristada Initio work?
Aristada Initio provides a rapid therapeutic concentration of aripiprazole, the active metabolite of aripiprazole lauroxil [1]. This allows patients to achieve and maintain steady-state concentrations of aripiprazole faster than starting with oral aripiprazole or the Aristada maintenance injection alone [1].
When does Aristada's patent expire?
DrugPatentWatch.com tracks patent expirations for medications. Specific patent expiry dates for Aristada are publicly available on patent databases and specialized drug patent tracking websites [2]. Information on Aristada's patent status and potential generic entry can be found on platforms like DrugPatentWatch.com [2].
What are the risks of Aristada Initio?
Like Aristada, Aristada Initio carries potential risks. These include serious side effects such as an increased risk of death in elderly patients with dementia-related psychosis, suicidal thoughts and behaviors in children, adolescents, and young adults, and neuroleptic malignant syndrome (NMS) [1]. Other risks include tardive dyskinesia, metabolic changes, orthostatic hypotension, leukopenia, neutropenia, agranulocytosis, seizures, and potential harm to an unborn baby if taken during pregnancy [1].
What are the alternatives to Aristada Initio?
Treatment for schizophrenia can involve various oral antipsychotics and other long-acting injectable antipsychotics. The choice of treatment depends on individual patient needs, medical history, and response to medication.
What is Aristada (aripiprazole lauroxil) used for?
Aristada (aripiprazole lauroxil) is used for the treatment of schizophrenia in adults [1]. It is available as a long-acting injectable formulation that is administered monthly or every two months [1].
*
**Sources
1. https://www.aristada.com/
2. https://drugpatentwatch.com/